Healthcare [ 7/13 ] | Biotechnology [ 82/163 ]
NYSE MKT | Common Stock
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.
The company develops OA-201, a small molecule formulation for the treatment of OAK pain.
Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 27, 24 | -2.48 Decreased by -1.34 K% | - |
| Nov 14, 23 | -1.53 Decreased by -259.35% | - |
| Aug 8, 23 | -0.09 Decreased by -808.00% | - |
| May 8, 23 | -0.26 Decreased by -1.22 K% | -0.30 Increased by +12.13% |
| Mar 27, 23 | -0.17 Decreased by -330.00% | -0.02 Decreased by -760.00% |
| Nov 14, 22 | -0.43 Decreased by -2.03 K% | -0.02 Decreased by -2.03 K% |
| Aug 9, 22 | -0.01 Increased by +50.00% | -0.02 Increased by +50.00% |
| May 16, 22 | -0.02 Increased by 0.00% | -0.02 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 0.00 Decreased by N/A% | -2.05 M Increased by +2.42% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.23 M Increased by +81.07% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.37 M Increased by +34.78% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -3.67 M Increased by +34.83% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -2.10 M Increased by +66.18% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -6.49 M Decreased by -78.91% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -2.10 M Increased by +40.89% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -5.64 M Decreased by -53.78% | Decreased by N/A% Decreased by N/A% |